FDA inspection

Cadila Healthcare Limited, Dabhasa: FDA inspection ending May 6, 2004

FDA inspection 332018 · No Action Indicated (NAI) · Dabhasa

Key facts

Inspection ID 332018
Firm Cadila Healthcare Limited, Dabhasa
FEI number 3002806475
Address 31 Plots 26 - 29, Village Dabhasa
City Dabhasa
Fiscal year 2004
Inspection end date May 6, 2004
Classification No Action Indicated (NAI)
Project area Generic Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections